Clinical Laserthermia Systems AB B CLS B
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 1.77
- Day Range
- SEK 1.61–1.77
- 52-Week Range
- SEK 1.61–9.98
- Bid/Ask
- SEK 1.71 / SEK 1.76
- Shares Outstanding
- 48.52M
- Market Cap
- SEK 85.39M
- Volume/Avg
- 30,029 / 64,011
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.26
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 13
- Website
- https://www.clinicallaser.se
Valuation
|
Metric
|
CLS B
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.16 |
Price/Sales | 4.26 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CLS B
|
|---|---|
Quick Ratio | 0.50 |
Current Ratio | 0.94 |
Interest Coverage | −253.30 |
Quick Ratio
CLS B
Profitability
|
Metric
|
CLS B
|
|---|---|
Return on Assets (Normalized) | −59.65% |
Return on Equity (Normalized) | −67.79% |
Return on Invested Capital (Normalized) | −71.00% |
Return on Assets
CLS B
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|lNj@#j% | LOCK|?mw&F | $184B | |||
| Medtronic PLC
MDT
| LOCK|P%>X$#N | LOCK|$C&Nm | $123B | |||
| Stryker Corp
SYK
| LOCK|kh?xC?hk | LOCK|Q? | $111B | |||
| Boston Scientific Corp
BSX
| LOCK|@cnz%@Y | LOCK|?%Mz | $61B | |||
| Edwards Lifesciences Corp
EW
| LOCK|X?@&<N>d | LOCK|GKQt& | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|>KhTY$ | LOCK|xK | $35B | |||
| DexCom Inc
DXCM
| LOCK|L<f$^TW | LOCK|dpgjc | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|kfN | LOCK|xjl | $26B | |||
| Steris PLC
STE
| LOCK|Rl^@?k$ | LOCK|%SW%R | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|P$^H?^% | LOCK|XC$ | $18B |
United States